Streetbeat News

Stock Prices

TECK

Teck Resources shares are trading lower following mixed Q2 earnings results.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:39 am

BSX

Boston Scientific has updated its 2024 net sales growth estimates to 13.5%-14.5% on a reported basis and 13%-14% on an organic basis, which is an increase from the prior guidance of 11%-13% and 10%-12%, respectively.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:38 am

ENPH

Enphase Energy shares are trading higher despite reporting worse-than-expected Q2 earnings and guidance with a midpoint below estimates.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:37 am

TXN

Texas Instruments shares are trading higher following a Q2 earnings beat and strong Q3 guidance.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:37 am

BSX

Boston Scientific shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:36 am

T

AT&T projects a 3% growth in wireless service revenue and a 7% growth in broadband revenue for FY24.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:35 am

SAGE

Sage Therapeutics shares are trading lower after the Phase 2 KINETIC 2 study of SAGE-324 did not demonstrate a statistically significant dose-response relationship on the primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:34 am

BIIB

SAGE

Sage Therapeutics and Biogen reported results from their Phase 2 KINETIC 2 study of SAGE-324 (BIIB124) for essential tremor. The study did not demonstrate a statistically significant dose-response relationship on the primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:34 am

GEV

GE Vernova shares are trading higher after the company raised its FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:28 am

GEV

GE Vernova has raised its FY24 revenue guidance to the higher end of the $34B-$35B range, surpassing the $34.63B estimate. The company also increased its FY24 adjusted EBITDA margin guidance to 5%-7% and its FY24 free cash flow guidance to $1.3B-$1.7B.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:28 am